无异常子宫出血女性子宫内膜病变的超声特征:国际子宫内膜肿瘤分析研究(IETA3)结果
国际子宫内膜肿瘤分析(IETA3)前瞻性观察研究纳入1745例无异常子宫出血(AUB)女性,采用IETA术语行经阴道超声检查并获取组织学诊断。组织学显示子宫内膜癌和/或子宫内膜上皮内瘤变29例(1.7%),息肉1028例(58.9%)。无AUB女性中,无症状息肉或子宫内膜恶性肿瘤的子宫内膜似乎更薄且血流信号更少。
要点
- 无AUB女性中子宫内膜癌或EIN仅1.7%,但86.2%(25/29)在绝经后诊断。
- 无AUB女性子宫内膜癌或EIN平均内膜厚度11.2 mm,较良性病变厚2.4 mm。
- 无AUB女性子宫内膜息肉最常见血管模式为单根优势血管(64.8%)。
核心结论
- 采用IETA术语描述了无AUB女性子宫内膜癌、息肉及其他宫腔内组织学类型的典型超声特征;无症状息肉或子宫内膜恶性肿瘤可能伴随更薄且血流信号更少的子宫内膜。
研究设计与样本
- 前瞻性观察研究,纳入7个妇科超声专科中心2011年至2018年因非AUB适应症就诊的1745例女性,行标准化经阴道超声(IETA检查与测量技术)后行子宫内膜取样组织学诊断(n=1537)或至少1年临床与超声随访(n=208)。
关键影像表现/征象
- 无AUB女性子宫内膜癌或EIN平均内膜厚度11.2 mm(95%CI 8.9-13.6 mm),较良性病变平均厚2.4 mm(95%CI 0.3-4.6 mm)。
- 子宫内膜癌或EIN组非均匀回声22/29(75.9%)vs 良性组929/1716(54.1%),差异+21.8%(95%CI +4.2%至+39.2%)。
- 子宫内膜癌或EIN组中至丰富血流(color score 3-4)9/29(31.0%)vs 良性组220/1716(12.8%),差异+18.2%(95%CI -0.5%至+36.9%)。
- 子宫内膜癌或EIN组多发性多灶血管7/29(24.1%)vs 良性组68/1716(4.0%),差异+20.2%(95%CI +4.6%至+35.7%)。
- 子宫内膜癌或EIN组内膜-肌层交界规则19/29(65.5%)vs 良性组1412/1716(82.3%),差异-16.8%(95%CI -34.2%至+0.6%)。
诊断标准与关键数值
- 无AUB女性子宫内膜息肉最常见血管模式为单根优势血管666/1028(64.8%)。
- 无AUB女性子宫内膜癌或EIN平均内膜厚度11.2 mm(95%CI 8.9-13.6 mm),较良性病变厚2.4 mm(95%CI 0.3-4.6 mm)。
- 无AUB女性子宫内膜癌或EIN非均匀回声75.9%(22/29)vs 良性54.1%(929/1716),差异+21.8%(95%CI +4.2%至+39.2%)。
- 无AUB女性子宫内膜癌或EIN color score 3-4为31.0%(9/29)vs 良性12.8%(220/1716),差异+18.2%(95%CI -0.5%至+36.9%)。
- 无AUB女性子宫内膜癌或EIN多发性多灶血管24.1%(7/29)vs 良性4.0%(68/1716),差异+20.2%(95%CI +4.6%至+35.7%)。
临床应用与阅片要点
- 无AUB女性中子宫内膜癌或EIN多数(25/29,86.2%)在绝经后诊断,阅片时需结合绝经状态评估内膜。
- 无AUB女性子宫内膜癌或EIN平均内膜厚度11.2 mm(95%CI 8.9-13.6 mm),较良性病变厚2.4 mm(95%CI 0.3-4.6 mm)。
- 无AUB女性子宫内膜息肉最常见血管模式为单根优势血管(64.8%),可作为识别息肉的血管征象。
- 无AUB女性子宫内膜癌或EIN多发性多灶血管出现率24.1%(7/29),高于良性病变的4.0%(68/1716)。
- 无AUB女性子宫内膜癌或EIN内膜-肌层交界规则出现率65.5%(19/29),低于良性病变的82.3%(1412/1716),差异未达统计学显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The primary aim of this study was to describe the ultrasound features of various endometrial and other intracavitary pathologies in women without abnormal uterine bleeding (AUB) using the International Endometrial Tumor Analysis (IETA) terminology. The secondary aim was to compare our findings with published data on women with AUB.
METHODS: This was a prospective observational study of women presenting at one of seven centers specialized in gynecological ultrasonography, from 2011 until 2018, for indications unrelated to AUB. All patients underwent transvaginal ultrasound using the IETA examination and measurement techniques. Ultrasonography was performed as part of routine gynecological examination or follow-up of non-endometrial pathology, or as part of the work-up before undergoing treatment for infertility, uterine prolapse or ovarian pathology. Ultrasound findings were described using the IETA terminology. Endometrial sampling was performed after the ultrasound scan. The histological endpoints were endometrial atrophy, proliferative or secretory endometrium, endometrial hyperplasia without atypia, endometrial polyp, intracavitary leiomyoma, endometrial intraepithelial neoplasia (EIN), endometrial cancer (EC) and insufficient tissue. The findings in our cohort of women without AUB were compared with those in a published cohort of women with AUB who were examined with transvaginal ultrasound between 2012 and 2015 using the same IETA examination technique and terminology.
RESULTS: In this study (IETA3), we included 1745 women without AUB who underwent a standardized transvaginal ultrasound examination followed by either endometrial sampling with histological diagnosis (n = 1537) or at least 1 year of clinical and ultrasound follow-up (n = 208). Of these, 858 (49.2%) women were premenopausal and 887 (50.8%) were postmenopausal. Histology showed the presence of EC and/or EIN in 29 (1.7%) women, endometrial polyps in 1028 (58.9%), intracavitary myomas in 66 (3.8%), proliferative or secretory changes or hyperplasia without atypia in 144 (8.3%), endometrial atrophy in 265 (15.2%) and insufficient tissue in five (0.3%). Most cases of EC or EIN (25/29 (86.2%)) were diagnosed after menopause. The mean endometrial thickness in women with EC or EIN was 11.2 mm (95% CI, 8.9-13.6 mm), being on average 2.4 mm (95% CI, 0.3-4.6 mm) thicker than their benign counterparts. Women with malignant endometrial pathology manifested more frequently non-uniform echogenicity (22/29 (75.9%)) than did those with benign endometrial pathology (929/1716 (54.1%)) (difference, +21.8% (95% CI, +4.2% to +39.2%)). Moderate to abundant vascularization (color score 3-4) was seen in 31.0% (9/29) of cases with EC or EIN compared with 12.8% (220/1716) of those with a benign outcome (difference, +18.2% (95% CI, -0.5% to +36.9%)). Multiple multifocal vessels were recorded in 24.1% (7/29) women with EC or EIN vs 4.0% (68/1716) of those with a benign outcome (difference, +20.2% (95% CI, +4.6% to +35.7%)). A regular endometrial-myometrial junction was seen less frequently in women with EC or EIN (19/29 (65.5%)) vs those with a benign outcome (1412/1716 (82.3%)) (difference, -16.8% (95% CI, -34.2% to +0.6%)). In women with endometrial polyps without AUB, a single dominant vessel was the most frequent vascular pattern (666/1028 (64.8%)). In women with EC, both in those with and those without AUB, the endometrium usually manifested heterogeneous echogenicity, but the endometrium was on average 8.6 mm (95% CI, 5.2-12.0 mm) thinner and less intensely vascularized (color score 3-4: difference, -26.8% (95% CI, -52.2% to -1.3%)) in women without compared to those with AUB. In both pre- and postmenopausal women, asymptomatic endometrial polyps were associated with a thinner endometrium, and they manifested more frequently a bright edge, a regular endometrial-myometrial junction and a single dominant vessel than did polyps in symptomatic women, and they were less intensely vascularized.
CONCLUSIONS: We describe the typical ultrasound features of EC, polyps and other intracavitary histologies using IETA terminology in women without AUB. Our findings suggest that the presence of asymptomatic polyps or endometrial malignancy may be accompanied by thinner and less intensely vascularized endometria than their symptomatic counterparts. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Heremans R, Van Den Bosch T, Valentin L, et al. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3). Ultrasound Obstet Gynecol. 2022. PMID: 35385178. doi:10.1002/uog.24910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。